CPV 33-1 Medical equipment instruments

About CPV 33-1

CPV 33-1 is the Common Procurement Vocabulary group covering medical equipment and instruments. It sits inside division 33 and is the device half of it, distinct from pharmaceuticals in group 33-6 and from personal care products elsewhere in the division.

The group covers imaging and diagnostic equipment, surgical instruments and theatre equipment, patient monitoring, endoscopy, dialysis and infusion equipment, ventilators and respiratory devices, dental and ophthalmic equipment, rehabilitation and mobility devices, and in vitro diagnostic instruments.

The buying pattern is unusual because it operates at two levels simultaneously. National aggregation handles high-volume commodity devices and consumables, while individual trusts and health boards run their own competitions for capital equipment where clinical preference, existing estate, and service arrangements make local choice necessary.

Active CPV 33-1 tenders

Capital equipment replacement is the largest visible stream. Imaging equipment, theatre systems, endoscopy stacks, and monitoring fleets are replaced on cycles driven by age, service support availability, and capital allocation, and are procured trust by trust or through collaborative arrangements between neighbouring organisations.

Diagnostic capacity expansion has generated sustained procurement, driven by demand for imaging and endoscopy beyond existing capacity. Managed equipment services, where a supplier provides, maintains and replaces a whole category of equipment for a fee over many years, are a significant and growing procurement type.

Active sub-category	Typical procurement route	Primary buyer pattern
Capital imaging equipment	Trust-level competition	NHS trust or health board
Surgical and theatre equipment	Framework call-off	Trust or national aggregator
Patient monitoring	Trust or regional competition	NHS trust
Consumables and standard devices	National aggregated supply	Central NHS procurement body
Managed equipment services	Long-term bespoke procurement	Large trust or health system

Top buyers procuring CPV 33-1

In our own corpus NHS National Services Scotland, appearing under more than one normalised name, is the most frequent publisher under this group, alongside the University of Glasgow, Supply Chain Coordination Limited, the University of Edinburgh, and NHS Wales Shared Services Partnership.

That mix reflects the structure of UK health procurement. Scotland and Wales both operate central procurement bodies purchasing on behalf of health boards, which concentrates notice volume. Supply Chain Coordination Limited manages the central supply function for the English NHS. Universities appear because medical instrument procurement overlaps substantially with biomedical research equipment, and the boundary between clinical and research devices is porous.

Typical contract values under CPV 33-1

The median notice sits around two million pounds, and the upper decile reaches well beyond two hundred million. Medical equipment is expensive, contracts frequently bundle equipment with multi-year maintenance, and managed equipment service arrangements aggregate an entire category across a long term.

Suppliers should distinguish carefully between the capital price and the whole-life cost, because buyers evaluate on the latter. Service contracts, consumables that only fit one manufacturer's device, software licensing, and the cost of eventual replacement all feed the evaluation. A device with a lower purchase price and expensive proprietary consumables frequently loses to a more costly device with open consumables, and buyers have become considerably more alert to lifetime lock-in than they once were.

Compliance and certifications for CPV 33-1 bidders

Medical device regulatory compliance is the fundamental requirement. Devices must carry appropriate conformity marking for the UK market under the applicable medical devices regulations, with the transitional arrangements the regulator has set, and buyers require evidence covering the specific device and its intended clinical use rather than a general certificate.

ISO 13485 quality management certification is the practical entry requirement for manufacturers, and ISO 14971 risk management evidence is commonly requested. Connected devices attract digital assessment requirements covering security, interoperability, and clinical safety, including a documented hazard analysis and named clinical safety officer where software is involved. Data protection obligations apply where devices process patient data. Suppliers should also expect requirements around training for clinical users, response times for service, availability of spares and consumables for the device's expected life, and decommissioning and data destruction at end of life.

Frequently asked questions

Should I sell to individual trusts or to the central procurement bodies?

Both, and the answer differs by product. Commodity devices and consumables bought in volume are aggregated centrally, so central framework admission is the route. Capital equipment where clinical preference matters is bought at trust or health board level, and there the sales process is clinical engagement as much as procurement response, because the specification originates with the clinical team. Suppliers of capital equipment who focus only on central frameworks miss most of their market, and suppliers of consumables who focus only on trusts waste effort.

How much does clinical preference drive the outcome?

Considerably, and legitimately so. Clinicians who will use a device have a genuine stake in its usability, compatibility with their technique, and integration with existing equipment, and buyers involve them in specification and evaluation. That is why supplier engagement with clinical teams, including evaluation loans and trials, matters as much as the tender response. It is also why buyers are careful to specify by performance rather than by brand, and why a supplier believing a specification is unfairly narrow should raise it during clarification.

What is a managed equipment service and is it worth pursuing?

It is an arrangement where a supplier provides, maintains, refreshes, and sometimes operates a whole category of equipment across a hospital or health system for an annual fee over a long period, typically well over a decade. For the buyer it converts capital cost into operating cost and transfers obsolescence risk. For a supplier it is a large, long, and demanding commitment requiring financing capability and service infrastructure, and it is realistically available only to major manufacturers or consortia. Smaller suppliers more often participate as subcontractors supplying particular equipment within the arrangement.

How does this group relate to CPV 38?

They overlap at the diagnostic laboratory boundary, and buyers code inconsistently there. An analyser for a clinical pathology laboratory may be coded as medical equipment here or as a scientific instrument under CPV 38. The distinction matters practically because clinical use brings the medical device regulatory regime into play with substantially heavier compliance requirements, while a research-only instrument does not carry them. Suppliers serving both markets should watch both codes and should be clear which regulatory regime applies to the specific application.